What’s Behind Incyte’s Better-Than-Expected Q4 Earnings

1 min read

Incyte (NASDAQ: INCY) hasn’t exactly been a highflier in recent years. Over the last five years, the stock is up less than 30%. During that same period, the S&P 500 more than doubled.  

The biotech reported its fourth-quarter results before the market opened on Tuesday. Did Incyte give any reasons for investors to raise their expectations? Here are highlights from the company’s quarterly update.

Image source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Avient Corporation (AVNT) Q4 2020 Earnings Call Transcript

Next Story

Why Varonis Stock Jumped Today

Latest from Blog